Diffusion of macromolecules through sclera

Acta Ophthalmologica

Volumn 91, Issue 1, 2013, Pages

  Miao, Heng ^a,b   Wu, Bi Dong ^c   Tao, Yong ^a,b   Li, Xiao Xin ^a,b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

diffusion; macromolecule; porcine; sclera

Indexed keywords

DEXTRAN; FLUORESCEIN ISOTHIOCYANATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DIFFUSION CHAMBER; FLUORESCENCE MICROSCOPY; FROZEN SECTION; IN VITRO STUDY; MACROMOLECULE; MOLECULAR WEIGHT; NONHUMAN; PERMEABILITY COEFFICIENT; PHYSICAL PARAMETERS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCLERA; SCLERA THICKNESS; SPECTROFLUOROMETRY; VISUAL SYSTEM PARAMETERS;

ANIMALS; BIOLOGICAL TRANSPORT; DEXTRANS; DIFFUSION CHAMBERS, CULTURE; FACILITATED DIFFUSION; FLUORESCEIN-5-ISOTHIOCYANATE; MACROMOLECULAR SUBSTANCES; MICROSCOPY, FLUORESCENCE; MOLECULAR WEIGHT; PERMEABILITY; SCLERA; SPECTROMETRY, FLUORESCENCE; SWINE;

EID: 84873056797     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2012.02557.x     Document Type: Article

References (25)

1. Ambati J, &, Adamis AP, (2002): Transscleral drug delivery to the retina and choroid. Prog Retin Eye Res 21: 145-151.
2. Ambati J, Canakis CS, Miller JW, et al., (2000): Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci 41: 1181-1185.
3. Anderson OA, Jackson TL, Singh JK, et al., (2008): Human transscleral albumin permeability and the effect of topographical location and donor age. Invest Ophthalmol Vis Sci 49: 4041-4045.
4. Bae JH, Lee CS, &, Lee SC, (2011): Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Retina 31: 111-118.
5. Boubriak OA, Urban JP, Akhtar S, et al., (2000): The effect of hydration and matrix composition on solute diffusion in rabbit sclera. Exp Eye Res 71: 503-514.
6. Cheruvu NP, &, Kompella UB, (2006): Bovine and porcine transscleral solute transport: influence of lipophilicity and the choroid-Bruch's layer. Invest Ophthalmol Vis Sci 47: 4513-4522.
7. Comparison of Age-related Macular Degeneration Treatments trials (CATT) Rearch Group, et al. (2012): Ranibizumab and Bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 119: 1388-1398.
8. Cruysberg LP, Nuijts RM, Geroski DH, et al., (2005): The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds. Invest Ophthalmol Vis Sci 46: 3790-3794.
9. Edwards A, &, Prausnitz MR, (1998): Fiber matrix model of sclera and corneal stroma for drug delivery to the eye. Am Inst Chem Eng J 44: 214-225.
10. Horner PJ, &, Gage FH, (2000): Regenerating the damaged central nervous system. Nature 407: 963-970.
11. Jain RK, (1985): Transport of macromolecules in tumor microcirculation. Biotechnol Prog 1: 81-94.
12. Lindsay RM, (1996): Therapeutic potential of the neurotrophins and neurotrophin-CNTF combinations in peripheral neuropathies and motor neuron diseases. Ciba Found Symp 196: 39-48.
13. Maurice D, (2001): Review: practical issues intravitreal drug delivery. J Ocul Pharmacol Ther 17: 393-401.
14. Nicoli S, Ferrari G, Quata M, Macaluso C, et al., (2009): Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability. Mol Vis 15: 259-266.
15. Nugent LJ, Jain RK, (1984): Plasma pharmacokinetics and interstitial diffusion of macromolecules in a capillary bed. Am J Physiol 1984; 246: H129-H137.
16. Olsen TW, Edelhauser HF, Lim JI, &, Geroski DH, (1995): Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis Sci 36: 1893-1903.
17. Olsen TW, Aaberg SY, Geroski DH, &, Edelhauser HF, (1998): Human sclera: thickness and surface area. Am J Ophthalmol 125: 237-241.
18. Prausnitz MR, et al., (1998): Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci; 87: 1479-1488.
19. Robinson MR, Lee SS, Kim H, et al., (2006): A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp Eye Res 82: 479-487.
20. Schoenwald RD, (1990): Ocular drug delivery. Pharmacokinetic considerations. Clin Pharmacokinet 18: 255-269.
21. Schoenwald RD, (1993): Ocular pharmacokinetics/pharmacodynamics. In:, Mitra A, (ed.) Ophthalmic Drug Delivery System. New York, NY: Marcel Dekker 83-110.
22. Schröder U, Arfors KE, &, Tangen O, (1976): Stability of fluorescein labeled dextrans in vivo and in vitro. Microvasc Res 11: 33-39.
23. Tao Y, Li X-X, Jiang Y-R, et al., (2007): Diffusion of macromolecule through retina after experimental branch retinal vein occlusion and estimate of intraretinal barrier. Curr Drug Metab 8: 151-156.
24. Weinreb RN, (2001): Enhancement of scleral macromolecular permeability with prostaglandins. Trans Am Ophthalmol Soc 99: 319-343.
25. Yalcinbayir O, Gelisken O, Kaderli B, et al., (2011): Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema. Ophthalmologica 225: 222-227.